Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Kinsale Capital Group, Inc. stock logo
KNSL
Kinsale Capital Group
$442.57
-1.1%
$446.86
$405.00
$531.79
$10.31B1.09208,129 shs76,174 shs
Medpace Holdings, Inc. stock logo
MEDP
Medpace
$540.94
+2.4%
$492.23
$250.05
$547.15
$15.17B1.4424,034 shs79,991 shs
MSCI Inc stock logo
MSCI
MSCI
$533.44
-0.2%
$563.02
$486.73
$642.45
$41.25B1.33610,084 shs244,548 shs
Zoetis Inc. stock logo
ZTS
Zoetis
$145.40
+0.9%
$148.73
$139.34
$193.00
$64.45B0.93.03 million shs713,957 shs
Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Kinsale Capital Group, Inc. stock logo
KNSL
Kinsale Capital Group
0.00%-4.85%+4.43%-6.19%-5.52%
Medpace Holdings, Inc. stock logo
MEDP
Medpace
0.00%+5.36%+5.91%+70.96%+48.17%
MSCI Inc stock logo
MSCI
MSCI
0.00%-2.16%-4.48%-7.60%-12.02%
Zoetis Inc. stock logo
ZTS
Zoetis
0.00%+2.20%-1.15%-2.15%-25.42%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Kinsale Capital Group, Inc. stock logo
KNSL
Kinsale Capital Group
$442.57
-1.1%
$446.86
$405.00
$531.79
$10.31B1.09208,129 shs76,174 shs
Medpace Holdings, Inc. stock logo
MEDP
Medpace
$540.94
+2.4%
$492.23
$250.05
$547.15
$15.17B1.4424,034 shs79,991 shs
MSCI Inc stock logo
MSCI
MSCI
$533.44
-0.2%
$563.02
$486.73
$642.45
$41.25B1.33610,084 shs244,548 shs
Zoetis Inc. stock logo
ZTS
Zoetis
$145.40
+0.9%
$148.73
$139.34
$193.00
$64.45B0.93.03 million shs713,957 shs
Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Kinsale Capital Group, Inc. stock logo
KNSL
Kinsale Capital Group
0.00%-4.85%+4.43%-6.19%-5.52%
Medpace Holdings, Inc. stock logo
MEDP
Medpace
0.00%+5.36%+5.91%+70.96%+48.17%
MSCI Inc stock logo
MSCI
MSCI
0.00%-2.16%-4.48%-7.60%-12.02%
Zoetis Inc. stock logo
ZTS
Zoetis
0.00%+2.20%-1.15%-2.15%-25.42%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Kinsale Capital Group, Inc. stock logo
KNSL
Kinsale Capital Group
2.45
Hold$506.8914.53% Upside
Medpace Holdings, Inc. stock logo
MEDP
Medpace
1.94
Reduce$430.60-20.40% Downside
MSCI Inc stock logo
MSCI
MSCI
2.86
Moderate Buy$647.7021.42% Upside
Zoetis Inc. stock logo
ZTS
Zoetis
2.44
Hold$196.7135.30% Upside

Current Analyst Ratings Breakdown

Latest ZTS, KNSL, MEDP, and MSCI Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
10/20/2025
Zoetis Inc. stock logo
ZTS
Zoetis
UBS Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price Target$158.00
10/17/2025
Medpace Holdings, Inc. stock logo
MEDP
Medpace
Mizuho
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetOutperform$510.00 ➝ $575.00
10/14/2025
MSCI Inc stock logo
MSCI
MSCI
Evercore ISI
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetOutperform$588.00 ➝ $611.00
10/8/2025
Kinsale Capital Group, Inc. stock logo
KNSL
Kinsale Capital Group
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy (B-)
10/8/2025
Medpace Holdings, Inc. stock logo
MEDP
Medpace
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy (B-)
10/8/2025
MSCI Inc stock logo
MSCI
MSCI
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy (B-)
10/8/2025
Zoetis Inc. stock logo
ZTS
Zoetis
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingHold (C-)
10/7/2025
Kinsale Capital Group, Inc. stock logo
KNSL
Kinsale Capital Group
Morgan Stanley
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetOverweight$525.00 ➝ $500.00
10/1/2025
MSCI Inc stock logo
MSCI
MSCI
Seaport Res Ptn
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeStrong-Buy
9/27/2025
Kinsale Capital Group, Inc. stock logo
KNSL
Kinsale Capital Group
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy (B-)
9/27/2025
Medpace Holdings, Inc. stock logo
MEDP
Medpace
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy (B-)
(Data available from 10/20/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Kinsale Capital Group, Inc. stock logo
KNSL
Kinsale Capital Group
$1.59B6.50$16.18 per share27.36$63.75 per share6.94
Medpace Holdings, Inc. stock logo
MEDP
Medpace
$2.11B7.20$14.29 per share37.85$26.56 per share20.37
MSCI Inc stock logo
MSCI
MSCI
$2.86B14.45$17.98 per share29.67($11.99) per share-44.49
Zoetis Inc. stock logo
ZTS
Zoetis
$9.26B6.96$7.13 per share20.38$10.57 per share13.76
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Kinsale Capital Group, Inc. stock logo
KNSL
Kinsale Capital Group
$414.84M$19.1723.0821.041.6525.92%25.93%7.92%10/23/2025 (Estimated)
Medpace Holdings, Inc. stock logo
MEDP
Medpace
$404.39M$13.4540.1539.603.3118.74%67.66%21.86%10/22/2025 (Estimated)
MSCI Inc stock logo
MSCI
MSCI
$1.11B$15.1035.3128.022.6039.46%-143.13%23.46%10/28/2025 (Confirmed)
Zoetis Inc. stock logo
ZTS
Zoetis
$2.49B$5.8125.0321.542.3127.83%56.90%19.54%11/4/2025 (Estimated)

Latest ZTS, KNSL, MEDP, and MSCI Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
11/4/2025Q3 2025
Zoetis Inc. stock logo
ZTS
Zoetis
$1.64N/AN/AN/A$2.42 billionN/A
10/28/2025Q3 2025
MSCI Inc stock logo
MSCI
MSCI
$4.38N/AN/AN/A$794.87 millionN/A
10/23/2025Q3 2025
Kinsale Capital Group, Inc. stock logo
KNSL
Kinsale Capital Group
$4.66N/AN/AN/A$446.00 millionN/A
10/22/2025Q3 2025
Medpace Holdings, Inc. stock logo
MEDP
Medpace
$3.49N/AN/AN/A$640.49 millionN/A
8/5/2025Q2 2025
Zoetis Inc. stock logo
ZTS
Zoetis
$1.62$1.76+$0.14$1.61$2.41 billion$2.46 billion
7/24/2025Q2 2025
Kinsale Capital Group, Inc. stock logo
KNSL
Kinsale Capital Group
$4.41$4.78+$0.37$5.76$436.25 million$458.70 million
7/22/2025Q2 2025
MSCI Inc stock logo
MSCI
MSCI
$4.12$4.17+$0.05$3.92$763.06 million$772.68 million
7/21/2025Q2 2025
Medpace Holdings, Inc. stock logo
MEDP
Medpace
$3.00$3.10+$0.10$3.10$537.70 million$603.31 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Kinsale Capital Group, Inc. stock logo
KNSL
Kinsale Capital Group
$0.680.15%N/A3.55%2 Years
Medpace Holdings, Inc. stock logo
MEDP
Medpace
N/AN/AN/AN/AN/A
MSCI Inc stock logo
MSCI
MSCI
$7.201.35%N/A47.68%11 Years
Zoetis Inc. stock logo
ZTS
Zoetis
$2.001.38%N/A34.42%14 Years

Latest ZTS, KNSL, MEDP, and MSCI Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
10/9/2025
Zoetis Inc. stock logo
ZTS
Zoetis
quarterly$0.501.4%10/31/202510/31/202512/2/2025
8/18/2025
Kinsale Capital Group, Inc. stock logo
KNSL
Kinsale Capital Group
quarterly$0.170.15%8/29/20258/29/20259/11/2025
7/21/2025
MSCI Inc stock logo
MSCI
MSCI
quarterly$1.801.3%8/15/20258/15/20258/29/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Kinsale Capital Group, Inc. stock logo
KNSL
Kinsale Capital Group
0.11
0.10
0.10
Medpace Holdings, Inc. stock logo
MEDP
Medpace
N/A
0.43
0.43
MSCI Inc stock logo
MSCI
MSCI
N/A
0.86
0.86
Zoetis Inc. stock logo
ZTS
Zoetis
1.05
1.76
1.04

Institutional Ownership

CompanyInstitutional Ownership
Kinsale Capital Group, Inc. stock logo
KNSL
Kinsale Capital Group
85.36%
Medpace Holdings, Inc. stock logo
MEDP
Medpace
77.98%
MSCI Inc stock logo
MSCI
MSCI
89.97%
Zoetis Inc. stock logo
ZTS
Zoetis
92.80%

Insider Ownership

CompanyInsider Ownership
Kinsale Capital Group, Inc. stock logo
KNSL
Kinsale Capital Group
5.50%
Medpace Holdings, Inc. stock logo
MEDP
Medpace
20.30%
MSCI Inc stock logo
MSCI
MSCI
3.31%
Zoetis Inc. stock logo
ZTS
Zoetis
0.16%
CompanyEmployeesShares OutstandingFree FloatOptionable
Kinsale Capital Group, Inc. stock logo
KNSL
Kinsale Capital Group
47023.30 million22.02 millionOptionable
Medpace Holdings, Inc. stock logo
MEDP
Medpace
5,90028.09 million22.39 millionOptionable
MSCI Inc stock logo
MSCI
MSCI
6,13277.36 million74.80 millionOptionable
Zoetis Inc. stock logo
ZTS
Zoetis
13,800443.18 million442.47 millionOptionable

Recent News About These Companies

Lyell Wealth Management LP Reduces Position in Zoetis Inc. $ZTS
Stephens Inc. AR Raises Position in Zoetis Inc. $ZTS
Chevy Chase Trust Holdings LLC Grows Stake in Zoetis Inc. $ZTS
Research Analysts Issue Forecasts for Zoetis FY2025 Earnings
Zoetis (NYSE:ZTS) Shares Unloaded Rep. Rick Larsen
Leerink Partnrs Has Weak Outlook for Zoetis FY2025 Earnings
William Blair Issues Pessimistic Outlook for Zoetis Earnings

New MarketBeat Followers Over Time

Media Sentiment Over Time

Kinsale Capital Group stock logo

Kinsale Capital Group NYSE:KNSL

$442.57 -4.87 (-1.09%)
As of 01:37 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Kinsale Capital Group, Inc., a specialty insurance company, engages in the provision of property and casualty insurance products in the United States. The company's commercial lines offerings include commercial property, small business casualty and property, excess and general casualty, construction, allied health, life sciences, entertainment, energy, environmental, excess professional, health care, public entity, commercial auto, inland marine, aviation, ocean marine, product recall, and railroad, as well as product, professional, and management liability insurance. It markets and sells its insurance products in all 50 states, the District of Columbia, the Commonwealth of Puerto Rico, and the U.S. Virgin Islands primarily through a network of independent insurance brokers. The company was founded in 2009 and is headquartered in Richmond, Virginia.

Medpace stock logo

Medpace NASDAQ:MEDP

$540.93 +12.87 (+2.44%)
As of 01:37 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Medpace Holdings, Inc. engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. Its services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance. The company was founded by August James Troendle in 1992 and is headquartered in Cincinnati, OH.

MSCI stock logo

MSCI NYSE:MSCI

$533.44 -0.91 (-0.17%)
As of 01:37 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

MSCI Inc., together with its subsidiaries, provides critical decision support tools and solutions for the investment community to manage investment processes worldwide. The Index segment provides indexes for use in various areas of the investment process, including indexed financial product, such as ETFs, mutual funds, annuities, futures, options, structured products, and over-the-counter derivatives; performance benchmarking; portfolio construction and rebalancing; and asset allocation, as well as licenses GICS and GICS Direct. The Analytics segment offers risk management, performance attribution and portfolio management content, application, an integrated view of risk and return service, and an analysis of market, credit, liquidity, counterparty, and climate risk across asset classes; managed services, including consolidation of client portfolio data, review and reconciliation of input data and results, and customized reporting; and HedgePlatform to measure, evaluate, and monitor the risk of hedge fund investments. The ESG and Climate segment provides products and services that help institutional investors understand how ESG impacts the long-term risk and return of their portfolio and individual security-level investments; and data, ratings, research, and tools to help investors navigate increasing regulation. The All Other Private Assets segment includes real estate and infrastructure data, benchmarks, return-analytics, climate assessments and market insights; business intelligence to real estate owners, managers, developers, and brokers; and offers investment decision support tools for private capital. The Private Capital Solutions segment offers tools to help private asset investors across mission-critical workflows, such as sourcing terms and conditions, evaluating operating performance, managing risk and other activities supporting private capital investing. MSCI Inc. was incorporated in 1998 and is headquartered in New York, New York.

Zoetis stock logo

Zoetis NYSE:ZTS

$145.40 +1.34 (+0.93%)
As of 01:37 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.